Advertisement

Ads Placeholder
Loading...

Rite Aid Corporation

RADCQPNK
Healthcare
Medical - Pharmaceuticals
$0.01
$0.008(376.19%)
U.S. Market opens in 49h 11m

Rite Aid Corporation Fundamental Analysis

Rite Aid Corporation (RADCQ) shows weak financial fundamentals with a PE ratio of -0.00, profit margin of -2.99%, and ROE of 3.01%. The company generates $24.7B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position28740.12%
PEG Ratio-0.00

Areas of Concern

ROE3.01%
Operating Margin0.27%
We analyze RADCQ's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 145.7/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.

Fundamental Health Score

A
145.7/100

We analyze RADCQ's fundamental strength across five key dimensions:

Efficiency Score

Weak

RADCQ struggles to generate sufficient returns from assets.

ROA > 10%
-8.50%

Valuation Score

Excellent

RADCQ trades at attractive valuation levels.

PE < 25
-0.00
PEG Ratio < 2
-0.00

Growth Score

Weak

RADCQ faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

RADCQ maintains a strong and stable balance sheet.

Debt/Equity < 1
-9.79
Current Ratio > 1
1.22

Profitability Score

Weak

RADCQ struggles to sustain strong margins.

ROE > 15%
3.01%
Net Margin ≥ 15%
-2.99%
Positive Free Cash Flow
No

Key Financial Metrics

Is RADCQ Expensive or Cheap?

P/E Ratio

RADCQ trades at -0.00 times earnings. This suggests potential undervaluation.

-0.00

PEG Ratio

When adjusting for growth, RADCQ's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Rite Aid Corporation at -0.00 times its book value. This may indicate undervaluation.

-0.00

EV/EBITDA

Enterprise value stands at -16.61 times EBITDA. This is generally considered low.

-16.61

How Well Does RADCQ Make Money?

Net Profit Margin

For every $100 in sales, Rite Aid Corporation keeps $-2.99 as profit after all expenses.

-2.99%

Operating Margin

Core operations generate 0.27 in profit for every $100 in revenue, before interest and taxes.

0.27%

ROE

Management delivers $3.01 in profit for every $100 of shareholder equity.

3.01%

ROA

Rite Aid Corporation generates $-8.50 in profit for every $100 in assets, demonstrating efficient asset deployment.

-8.50%

Following the Money - Real Cash Generation

Operating Cash Flow

Rite Aid Corporation generates limited operating cash flow of $-53.68M, signaling weaker underlying cash strength.

$-53.68M

Free Cash Flow

Rite Aid Corporation generates weak or negative free cash flow of $-307.23M, restricting financial flexibility.

$-307.23M

FCF Per Share

Each share generates $-5.49 in free cash annually.

$-5.49

FCF Yield

RADCQ converts -536.18% of its market value into free cash.

-536.18%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-9.79

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.22

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

3.007

vs 25 benchmark

ROA

Return on assets percentage

-0.09

vs 25 benchmark

ROCE

Return on capital employed

0.01

vs 25 benchmark

How RADCQ Stacks Against Its Sector Peers

MetricRADCQ ValueSector AveragePerformance
P/E Ratio-0.0028.45 Better (Cheaper)
ROE300.66%763.00% Weak
Net Margin-2.99%-45265.00% (disorted) Weak
Debt/Equity-9.790.34 Strong (Low Leverage)
Current Ratio1.222795.60 Neutral
ROA-8.50%-16588.00% (disorted) Weak

RADCQ outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Rite Aid Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ